Evidence map›Paper›PMID 15131191›Full record

ArticleJournal of clinical microbiology2004

Comparison of VITEK 2 with ITS2-fragment length polymorphism analysis for identification of yeast species.

Caroline Massonet, Johan Van Eldere, Mario Vaneechoutte, Thierry De Baere, Jan Verhaegen, Katrien Lagrou

Abstract readComparative Study
In one paragraph

Article in Journal of clinical microbiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2013
    Article
  10. Article
  11. Article
  12. Article
  13. Evaluation of Pyrosequencing technology for the identification of clinically relevant non-dematiaceous yeasts and related species.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2008
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Identification and Antifungal Susceptibility Testing ofJournal of global infectious diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Caroline MassonetDepartment of Immunology and Microbiology, Rega Institute, U.Z. Gasthuisberg, B-3000 Leuven, Belgium. caroline.massonet@med.kuleuven.ac.be
Johan Van Eldere
Mario Vaneechoutte
Thierry De Baere
Jan Verhaegen
Katrien Lagrou

Funding

Wellcome Trust
6 · The paper itself

Abstract

A total of 61 clinical yeast isolates of Candida, Cryptococcus, Blastoschizomyces, and Saccharomyces spp. were used to compare two identification techniques, VITEK 2 and ITS2-fragment length polymorphism analysis (ITS2-FLP), with ID32C as the reference method. ID32C identified 58 isolates correctly. ITS2-FLP with Instagene DNA extraction identified 59 isolates. ITS2-FLP combined with boiling-freezing DNA extraction identified 55 isolates. VITEK 2 identified 41 isolates correctly.

Indexed as

CandidaCryptococcusDNA, FungalHumansMycologyMycosesPolymerase Chain ReactionPolymorphism, GeneticSaccharomycesSaccharomycetalesYeastsDNA, Fungal

Identifiers

PMID15131191
PMCPMC404601

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.